An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects - ScienceDirect
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Kappa Receptors – Opioid Peptides
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Opioids in cancer: The κ‑opioid receptor (Review)
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role | Semantic Scholar
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Opioid Receptors Mnemonic | Epomedicine
Mu Agonist Opioids and Kappa Opioids | Download Table
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile - British Journal of Anaesthesia